End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
11.82 CNY | +2.07% | +2.87% | +7.85% |
Apr. 19 | Hunan Fangsheng Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 10 | Fangsheng Pharma's Factories Pass GMP Inspection | MT |
Sales 2024 * | 2.1B 290M | Sales 2025 * | 2.51B 346M | Capitalization | 5.2B 718M |
---|---|---|---|---|---|
Net income 2024 * | 225M 31.07M | Net income 2025 * | 284M 39.22M | EV / Sales 2024 * | 2.47 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 2.07 x |
P/E ratio 2024 * |
23.2
x | P/E ratio 2025 * |
18.2
x | Employees | 1,686 |
Yield 2024 * |
0.85% | Yield 2025 * |
1.14% | Free-Float | 59.7% |
1 day | +2.07% | ||
1 week | +2.87% | ||
1 month | +7.85% | ||
3 months | +46.47% | ||
6 months | +7.55% | ||
Current year | +7.85% |
Managers | Title | Age | Since |
---|---|---|---|
Xiao Li Zhou
CEO | Chief Executive Officer | 51 | - |
Zai Chang Liu
DFI | Director of Finance/CFO | 50 | 21-06-16 |
43 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Xue Min Gao
BRD | Director/Board Member | 86 | 23-09-18 |
Shou Ying Du
BRD | Director/Board Member | 64 | 20-04-30 |
Xiong Yuan
BRD | Director/Board Member | 59 | 21-11-15 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 11.82 | +2.07% | 6,875,800 |
24-04-29 | 11.58 | +0.78% | 4,791,600 |
24-04-26 | 11.49 | -0.26% | 5,459,800 |
End-of-day quote Shanghai S.E., April 29, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+7.85% | 718M | |
+19.98% | 43.48B | |
+20.67% | 22.65B | |
+14.56% | 14.73B | |
+44.72% | 12.04B | |
-8.37% | 7.08B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+11.90% | 5.47B | |
-2.27% | 4.81B |
- Stock Market
- Equities
- 603998 Stock